Global disease prevalence: Chondrosarcoma is the second most common primary bone tumor worldwide; it has a high incidence rate among middle-aged and elderly populations and a relatively high rate of local recurrence.
Stage-based treatment for chondrosarcoma
Early treatment (when the tumor is localized and small, yielding good results)
involving wide surgical resection of the lesion—can effectively control tumor progression while preserving limb function to the greatest extent possible.
Intermediate-stage treatment (addressing local spread, inhibiting growth, and delaying progression)
employs a comprehensive approach—combining surgery with radiotherapy—to control further tumor spread and slow the rate of disease deterioration.
Treatment for advanced disease (distant metastasis; aimed at symptom relief and survival prolongation)
primarily employs systemic therapies such as chemotherapy, targeted therapy, and others to alleviate clinical symptoms and extend patient survival as much as possible.
Why choose Fosun Health for chondrosarcoma treatment
Fosun Health’s chondrosarcoma diagnosis and treatment services are managed by a specialized bone and soft tissue tumor center; the team has extensive experience in wide local excision, pelvic and spinal reconstruction, and the management of recurrent tumors.Leveraging a global medical network, patients have access to cutting-edge international options, including wide local excision, 3D-printed custom prosthesis reconstruction, CyberKnife M6 stereotactic radiosurgery, proton beam therapy, and targeted therapy.
For complex cases such as recurrent chondrosarcoma or tumors in surgically challenging locations, a multidisciplinary team (MDT)—comprising experts in orthopedic oncology surgery, radiation oncology, radiology, and pathology—collaborates to formulate the optimal treatment plan; a cross-border consultation mechanism enables patients to obtain second opinions from leading international medical centers.
Foshan Fosun Chancheng Hospital is equipped with the CyberKnife M6 precision radiotherapy system, enabling high-precision stereotactic radiosurgery for postoperative residual or recurrent chondrosarcoma.With extensive experience in wide resection and reconstructive surgery for chondrosarcoma, the hospital integrates precision radiotherapy and targeted therapy to provide patients with personalized, comprehensive care.
Treatment Methods for Chondrosarcoma
1.Wide tumor excision
For resectable chondrosarcoma, complete surgical resection is the primary local treatment modality; wide resection, reconstruction, or other appropriate surgical procedures may be selected based on the tumor's location, grade, and extent of invasion.
Treatment advantages:
① Complete resection: Direct removal of the primary tumor to achieve local control.
② Clarify pathology: The resected specimen allows for further assessment of tumor histological grade and margins.
③ Reduce local recurrence: Appropriate wide excision helps lower the risk of local residual disease.
④ Functional reconstruction: For lesions involving the limbs and areas around joints, reconstructive surgery can be combined to preserve limb function as much as possible.
2.CyberKnife precision radiotherapy
For select chondrosarcomas that cannot be completely surgically resected, are located in challenging areas, or exhibit local recurrence, the suitability of CyberKnife precision radiotherapy may be assessed based on lesion size, location, and the status of surrounding critical structures.
Treatment advantages:
① Precise focusing: Using image guidance to concentrate high-dose radiation on the target lesion.
② Non-surgical treatment: No traditional open surgery required; suitable for certain patients unsuitable for repeat surgery.
③ Protection of vital structures: Optimize dose distribution based on the spatial relationship between the tumor and surrounding vital organs.
④ Management of local recurrence: Can serve as a local treatment option for select cases of residual or recurrent local lesions.
3. VitalBeam linear accelerator precision radiotherapy
For select chondrosarcomas that are unresectable, incompletely resected, or recurrent, precision radiotherapy may be employed based on tumor location and the condition of surrounding normal tissues.
Treatment advantages:
① Precision irradiation: Formulate an individualized radiotherapy plan based on the extent of the tumor.
② Dose optimization: Improving target area coverage through treatment planning optimization.
③ Irradiation of complex sites: Precise dose planning can be performed for lesions located in complex anatomical regions such as the spine or pelvis.
④ Local treatment: Can be used for select cases involving surgically challenging or locally recurrent lesions.
4.Chemotherapy
Uses anticancer drugs to kill cancer cells systemically; effective against dedifferentiated chondrosarcoma and capable of effectively controlling tumor progression.
5.Targeted therapy
Precision targeting of specific gene mutation targets such as IDH1 offers new treatment options for some patients with chondrosarcoma.
6.Intraoperative cryoablation
Supplementing surgery with liquid nitrogen cryoablation destroys tumor cells via low temperatures, aiding in the elimination of residual lesions.
7.Neoadjuvant therapy
Using chemoradiotherapy prior to surgery to shrink the tumor creates more favorable conditions for subsequent surgical resection and increases the success rate.
8.Comprehensive therapy
Formulate an individualized comprehensive treatment plan based on the patient's specific condition, combining modalities such as surgery, radiotherapy, and chemotherapy to enhance therapeutic efficacy.
9.Supportive care
Approaches such as nutritional support, psychological counseling, and symptom management can comprehensively improve the patient's physical condition and quality of life.
Post-treatment care
Maintain a regular daily routine and engage in moderate functional exercises; avoid excessive weight-bearing on the affected limb; attend scheduled follow-ups and actively cooperate with further treatment as advised.
Post-treatment examinations
Periodic local MRI, chest CT, and follow-up imaging are required after treatment to timely detect local recurrence or pulmonary metastasis.
Conclusion
Chondrosarcoma poses a serious threat; the key to treatment lies in early detection, diagnosis, and intervention. Selecting an appropriate treatment plan and adhering to follow-up care helps improve quality of life.
